Related Experiment Videos
Avoiding drug interactions in hospitalized patients
David Juurlink1, Muhammad Mamdani, John Iazzetta
1Institute for Clinical Evaluative Sciences, Faculty of Medicine, University of Toronto.
Healthcare Quarterly (Toronto, Ont.)
|April 20, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Machine learning in the development and application of patient-reported outcome measures (PROMs) for surgical patients: a systematic review.
Journal of patient-reported outcomes·2026
VEGF as a predictor of major adverse events in patients with peripheral arterial disease - an exploratory study.
Journal of thrombosis and thrombolysis·2025
Responsible adoption of multimodal artificial intelligence in health care: promises and challenges.
The Lancet. Digital health·2025
Population Avoidable Days: A Novel Approach to an Old Problem.
Healthcare quarterly (Toronto, Ont.)·2026
Ambient Artificial Intelligence Scribes in Healthcare: A Governance Imperative for Canadian Health System Leaders.
Healthcare quarterly (Toronto, Ont.)·2026
Optimizing Opioid Addiction Treatment in Correctional Centres: Learnings From Alberta, Canada.
Healthcare quarterly (Toronto, Ont.)·2026
Toward a Quality Standard for Emergency Departments: A Commentary on Improving Mental Health and Substance Use Care for Youth in Canada.
Healthcare quarterly (Toronto, Ont.)·2026
Advancing a Digitally Enabled Supply Chain as a Strategy to Strengthen Resilience of Canada's Healthcare Supply Chain.
Healthcare quarterly (Toronto, Ont.)·2026
An "Early Warning" Risk Assessment Strategy to Enable Proactive Management of Supply Shortages in Canada.
Healthcare quarterly (Toronto, Ont.)·2026
Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis.
Phytotherapy research : PTR·2026
Multidimensional Exploration of Platinum Complexes for Cancer Therapy.
Angewandte Chemie (International ed. in English)·2026
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
Current opinion in endocrinology, diabetes, and obesity·2026